Evaluation of the protective effect of N-Acetyle-Cysteine versus placebo on the heart of diabetic patients undergoing CABG

Phase 2

• Conditions: Coronary artery bypass graft.; Atherosclerosis of coronary artery bypass graft(s), unspecified, with angina pectoris; I25.70

• Registration Number: IRCT20120215009014N202
• Lead Sponsor: Hamedan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: Male
• Target Recruitment: 240

Inclusion Criteria

Age of 45 to 75 years
Male gender
Diabetic
Candidate for undergoing CABG
Cardiac index at least 2.5 L/m2

Exclusion Criteria

Myocardial infarction after CABG
Moderate to severe Valvular disorder
Taking inotropic medication for a long time before or after surgery
Arm circumference larger than barometric cuff

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Assessing cardiac ejection fraction. Timepoint: before and 3 days after surgery. Method of measurement: using transthoracic echocardiography.;Assessing cardiac index. Timepoint: before and 3 days after surgery. Method of measurement: using transthoracic echocardiography.